Find Grants for Small Businesses (for-profit)

Find out if you qualify for verified grants for Small Businesses (for-profit). Discover your eligibility and key funding details for Small Businesses (for-profit) from major foundations and government agencies.

Total Dollars Available
$ 100 Trillion

Add Your Heading Text Here

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Deadline: October 8, 2027


Opportunity Number: PAR-25-248

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: October 8, 2027

Status: Posted

CFDA Numbers: 93.393

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-287

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-235

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.242, 93.879

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

Deadline: November 19, 2026


Opportunity Number: PAR-25-052

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 19, 2026

Status: Posted

CFDA Numbers: 93.853

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Deadline: October 14, 2027


Opportunity Number: PAR-25-135

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: October 14, 2027

Status: Posted

CFDA Numbers: 93.398

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Deadline: November 18, 2027


Opportunity Number: RFA-DA-26-034

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 18, 2027

Status: Posted

CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838

Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-112

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-113

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-105

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

NICHD Small Research Grant Program (R03 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PA-25-125

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-069

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-243

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-070

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Deadline: November 16, 2027


Opportunity Number: PAR-25-244

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.393

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-124

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Deadline: November 17, 2026


Opportunity Number: PAR-25-096

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.393, 93.121, 93.172, 93.866

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Deadline: November 6, 2026


Opportunity Number: PAR-25-095

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 6, 2026

Status: Posted

CFDA Numbers: 93.172, 93.393, 93.866, 93.121

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Deadline: May 4, 2028


Opportunity Number: PA-25-168

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: May 4, 2028

Status: Posted

CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-256

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.172

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-273

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.351

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Deadline: February 8, 2027


Opportunity Number: RFA-MH-26-170

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: February 8, 2027

Status: Posted

CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Deadline: November 5, 2026


Opportunity Number: PAR-25-255

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.172

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-203

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)

Deadline: April 20, 2027


Opportunity Number: RFA-ES-25-002

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: April 20, 2027

Status: Posted

CFDA Numbers: 93.113

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-027

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

    ×

    Request Grant Support from GTC 360° Advisors

    Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.